These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17308124)

  • 1. RETRACTED: mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
    Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
    Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
    Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
    Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
    Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H
    J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mda-9/Syntenin: a positive regulator of melanoma metastasis.
    Boukerche H; Su ZZ; Emdad L; Baril P; Balme B; Thomas L; Randolph A; Valerie K; Sarkar D; Fisher PB
    Cancer Res; 2005 Dec; 65(23):10901-11. PubMed ID: 16322237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
    Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
    Hwangbo C; Kim J; Lee JJ; Lee JH
    Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDA-9/syntenin is a key regulator of glioma pathogenesis.
    Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
    Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.
    Das SK; Bhutia SK; Sokhi UK; Azab B; Su ZZ; Boukerche H; Anwar T; Moen EL; Chatterjee D; Pellecchia M; Sarkar D; Fisher PB
    Cancer Res; 2012 Dec; 72(23):6217-26. PubMed ID: 23066033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1.
    Kim WY; Jang JY; Jeon YK; Chung DH; Kim YG; Kim CW
    Exp Mol Med; 2014 Apr; 46(4):e90. PubMed ID: 24722482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDA-9/syntenin: a positive gatekeeper of melanoma metastasis.
    Das SK; Bhutia SK; Kegelman TP; Peachy L; Oyesanya RA; Dasgupta S; Sokhi UK; Azab B; Dash R; Quinn BA; Kim K; Barral PM; Su ZZ; Boukerche H; Sarkar D; Fisher PB
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):1-15. PubMed ID: 22201728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
    Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
    PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
    Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
    Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    Glycoconj J; 2006 May; 23(3-4):221-32. PubMed ID: 16691505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma.
    Das SK; Bhutia SK; Azab B; Kegelman TP; Peachy L; Santhekadur PK; Dasgupta S; Dash R; Dent P; Grant S; Emdad L; Pellecchia M; Sarkar D; Fisher PB
    Cancer Res; 2013 Jan; 73(2):844-54. PubMed ID: 23233738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.
    Notarbartolo M; Labbozzetta M; Pojero F; D'Alessandro N; Poma P
    Curr Mol Med; 2018; 18(9):630-639. PubMed ID: 30608040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis.
    Yang JB; McCarthy JB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells.
    Philip S; Bulbule A; Kundu GC
    J Biol Chem; 2001 Nov; 276(48):44926-35. PubMed ID: 11564733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
    Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB
    Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis.
    Emdad L; Sarkar D; Su ZZ; Randolph A; Boukerche H; Valerie K; Fisher PB
    Cancer Res; 2006 Feb; 66(3):1509-16. PubMed ID: 16452207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.